A King’s College London study says hospitals and universities are running late-stage trials on repurposed generic drugs at less than 10% of the cost reported for pharmaceutical-company trials. The researchers argue this parallel system could help deliver affordable new treatments, with examples including drugs reused for blindness, breast cancer prevention, and Covid. [kcl.ac.uk]
Continue reading...
Continue reading...